AstraZeneca and Daiichi Sankyo have retracted their EU marketing application for datopotamab deruxtecan for advanced lung cancer due to regulatory feedback, while continuing its clinical development.
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.